NVDA vs SELX

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.

SELX presents a distressed financial profile, characterized by a Piotroski F-Score of 5/9 which suggests stable accounting health but masks severe operational failure. The company is suffering from a broken business model, evidenced by a negative gross margin (-24.46%) and an extreme operating margin of -402.62%. With revenue shrinking by 24.6% YoY and a catastrophic 5-year price decline of 95.6%, the company is in a state of fundamental collapse. The low Price/Sales ratio (0.17) is a value trap rather than a discount, as the company loses money on every unit sold.